CVR: 32879861
Secondary names: Vesper Biotechnology ApS
Previous names: INSUSENSE ApS
Vesper Bio ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named INSUSENSE ApS. The management consists of Jacob Falck Hansen. The company is owned by 75PMK Holding ApS and LUNDBECKFONDEN. The company has 3 employees. In 2025, the company reported a gross profit of DKK -36,446,130 and a net result of DKK -48,200,991 compared with DKK -66,506,349 the year before. Equity amounted to DKK -227,433,239.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at drive forsknings- og udviklingsvirksomhed rettet mod udvikling af lægemidler til behandling af hjernesygdomme, diabetes, diabetes-relaterede metaboliske, sygdomme, fedme og/eller fedmerelaterede sygdomme, samt at udføre aktiviteter, der er forbundet hermed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | -36.4 mio. | -48.2 mio. | 65.9 mio. | -227.4 mio. | 8 | |
| 2024 | -67.2 mio. | -66.5 mio. | 69.8 mio. | -179.2 mio. | 9 | |
| 2023 | -67.6 mio. | -52.6 mio. | 32.2 mio. | -112.7 mio. | 6 | |
| 2022 | -31.6 mio. | -36.9 mio. | 25.5 mio. | -60.2 mio. | 1 | |
| 2021 | -13.5 mio. | -16.5 mio. | 5.3 mio. | -23.3 mio. | 0 | |
| 2020 | -6.8 mio. | -8 mio. | 5.9 mio. | -6.8 mio. | 1 | |
| 2019 | - | -2.8 mio. | 1.8 mio. | 1.1 mio. | 1 | |
| 2018 | - | -4 mio. | 5.1 mio. | 3.9 mio. | 1 | |
| 2017 | - | -2.7 mio. | 9 mio. | 7.9 mio. | 0 | |
| 2016 | - | -4 mio. | 4 mio. | 3.1 mio. | - | |
| 2015 | - | -6.1 mio. | 8 mio. | 7.1 mio. | - | |
| 2014 | - | -6.9 mio. | 6.3 mio. | 5.6 mio. | - | |
| 2013 | - | -2.6 mio. | 12.9 mio. | 12.6 mio. | - | |
| 2012 | -22 t. | -16 t. | 380 t. | 377 t. | - |
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringCompared to 1.052 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Contact info changed: new phone: 23628367, new email: [email protected], new website: www.vesperbio.com (April 10, 2026).
Vesper Bio ApS has published its annual report for 2025. Gross profit came to DKK -36,446,130, and the net result was DKK -48,200,991.
As of June 25, 2025, Jacob Falck Hansen is registered as adm. dir. of Vesper Bio ApS.
As of June 25, 2025, Paul Brian Little has stepped down as adm. dir. of Vesper Bio ApS.
Vesper Bio ApS has published its annual report for 2024. Gross profit came to DKK -67,243,983, and the net result was DKK -66,506,349.
Vesper Bio ApS has published its annual report for 2023. Gross profit came to DKK -67,586,405, and the net result was DKK -52,563,302.
On November 10, 2023, the company changed its name from INSUSENSE ApS to Vesper Bio ApS.
Vesper Bio ApS has published its annual report for 2022. Gross profit came to DKK -31,619,749, and the net result was DKK -36,860,014.
Vesper Bio ApS has published its annual report for 2021. Gross profit came to DKK -13,498,842, and the net result was DKK -16,471,481.
Vesper Bio ApS has published its annual report for 2020. Gross profit came to DKK -6,780,427, and the net result was DKK -7,955,052.
Vesper Bio ApS has published its annual report for 2019. The net result was DKK -2,769,107.
Vesper Bio ApS has published its annual report for 2018. The net result was DKK -3,992,474.
As of October 1, 2018, Paul Brian Little is registered as adm. dir. of Vesper Bio ApS.
As of September 30, 2018, Christian Ellebæk Elling has stepped down as adm. dir. of Vesper Bio ApS.
Vesper Bio ApS has published its annual report for 2017. The net result was DKK -2,680,191.
As of December 15, 2017, 75PMK Holding ApS is registered as an owner of Vesper Bio ApS with an ownership share of 20%.
Vesper Bio ApS has published its annual report for 2016. The net result was DKK -4,003,407.
Vesper Bio ApS has published its annual report for 2015. The net result was DKK -6,065,152.
As of September 25, 2015, LUNDBECKFONDEN is registered as an owner of Vesper Bio ApS with an ownership share of 66%.
Vesper Bio ApS has published its annual report for 2014. The net result was DKK -6,940,347.
Vesper Bio ApS has published its annual report for 2013. The net result was DKK -2,554,127.
As of August 1, 2013, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Vesper Bio ApS.
As of August 1, 2013, JUT NR. 2124 ApS has stepped down as auditor of Vesper Bio ApS.
As of July 1, 2013, JUT NR. 2124 ApS has been appointed auditor of Vesper Bio ApS.
As of July 1, 2013, RSM DANMARK STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Vesper Bio ApS.
Vesper Bio ApS has published its annual report for 2012. Gross profit came to DKK -21,599, and the net result was DKK -16,199.
As of May 30, 2013, Christian Ellebæk Elling is registered as adm. dir. of Vesper Bio ApS.
As of May 30, 2013, Anders Nykjær has stepped down as adm. dir. of Vesper Bio ApS.
As of January 1, 2012, RSM DANMARK STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Vesper Bio ApS.
As of January 1, 2012, REVISIONSFIRMA SVENDSEN & SØRENSEN I/S has stepped down as auditor of Vesper Bio ApS.
As of April 19, 2010, REVISIONSFIRMA SVENDSEN & SØRENSEN I/S has been appointed auditor of Vesper Bio ApS.
As of April 19, 2010, Anders Nykjær is registered as adm. dir. of Vesper Bio ApS.
Vesper Bio ApS was founded on April 19, 2010.
Companies in the same industry and area
CVR 45506983
CVR 44695065
CVR 40172076
CVR 44828596
CVR 46314964
companydata.dk